Daewon Pharmaceutical Co (XKRX:003220) Margin of Safety % (DCF Earnings Based): N/A (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:003220 Daewon Pharmaceutical Co Ltd XKRX:003220
72 GF Score
Price ₩7,960.00
GF Value ₩14,490.07
Valuation Significantly Undervalued
! 9 Warning Signs
View Full Analysis

What is Daewon Pharmaceutical Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Daewon Pharmaceutical Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

XKRX:003220 vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Daewon Pharmaceutical Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daewon Pharmaceutical Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daewon Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Daewon Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) falls into.


XKRX:003220
72GF Score
Daewon Pharmaceutical Co Ltd XKRX:003220
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Daewon Pharmaceutical Co (XKRX:003220) Overvalued in 2026?

Based on GuruFocus' analysis, Daewon Pharmaceutical Co stock appears to be undervalued. The current stock price of ₩7,960.00 is trading 45.1% below its estimated GF Value™ of ₩14,490.07. GuruFocus considers Daewon Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for XKRX:003220:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₩14,490.07 vs. price of ₩7,960.00 (45.1% below fair value)
  • GF Score™: 72/100 with 9 warning signs

No single metric tells the full story. See the XKRX:003220 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daewon Pharmaceutical Co Business Description

Address 229-3 Yongdap-dong, Seongdong-gu, Seoul, KOR, 133-850
Daewon Pharmaceutical Co Ltd is active in the healthcare sector in Korea. Its main business involves antipyretics, respiratory drugs, cardiovascular drugs, and neuromuscular drugs. It also produces a range of health foods such as multivitamins. The company operates on a global basis.
72GF Score

Get the complete analysis for XKRX:003220

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩7,960.00
Price
₩14,490.07
GF Value